Colorectal and extracolonic cancer variations in MLH1/MSH2 hereditary nonpolyposis colorectal cancer kindreds and the general population - PubMed (original) (raw)
Colorectal and extracolonic cancer variations in MLH1/MSH2 hereditary nonpolyposis colorectal cancer kindreds and the general population
K M Lin et al. Dis Colon Rectum. 1998 Apr.
Abstract
Purpose: This clinical case review aimed to identify phenotypic variations in colorectal and extracolonic cancer expression between hereditary nonpolyposis colorectal cancer (HNPCC) families with MLH1 and MSH2 germline mutations and the general population.
Methods: Colorectal cancer onset and site distribution were compared among 67 members of MLH1 kindreds, 45 members of MSH2 kindreds, and 1,189 patients from the general population. Synchronous and metachronous cancer rates, tumor stage, extracolonic cancer incidence, and survival were also compared.
Results: Mean ages of colorectal cancer onset were 44, 46, and 69 years for MLH1, MSH2, and the general population, respectively (P < 0.001). More proximal and fewer distal colon cancers were noted in HNPCC than the general population (P < 0.001, P = 0.04). Site distribution showed disparity of rectal cancers (8 percent MLH1 vs. 28 percent MSH2; P = 0.01) based on genotypes. Overall, synchronous colorectal cancer rates were 7.4, 6.7, and 2.4 percent for MLH1, MSH2, and the general population, respectively (P = 0.016). Annual metachronous colorectal cancer rates were 2.1, 1.7, and 0.33 percent for MLH1, MSH2, and the general population, respectively (P = 0.041). Colorectal cancer stage presentation was lower in HNPCC than the general population (P = 0.0028). Extracolonic cancers were noted in 33 percent of MSH2 patients, compared with 12 percent of MLH1 patients and 7.3 percent of the general population with colorectal cancers (P < 0.001). Combined MLH1 and MSH2 ten-year survival was 68.7 percent compared with 47.8 percent for the general population (P = 0.009 stage stratified, hazard ratio 0.57).
Conclusion: The presence of rectal cancer should not preclude the diagnosis of HNPCC, because the incidence of rectal cancer in MSH2 was comparable with that in the general population. Phenotypic variations, including the preponderance of extracolonic cancers in MSH2 patients, did not result in survival differences between genotypic subgroups. These phenotypic features of HNPCC genotypes may have clinical significance in the design of specific screening, surveillance, and follow-up for affected individuals.
Similar articles
- Cumulative incidence of colorectal and extracolonic cancers in MLH1 and MSH2 mutation carriers of hereditary nonpolyposis colorectal cancer.
Lin KM, Shashidharan M, Thorson AG, Ternent CA, Blatchford GJ, Christensen MA, Watson P, Lemon SJ, Franklin B, Karr B, Lynch J, Lynch HT. Lin KM, et al. J Gastrointest Surg. 1998 Jan-Feb;2(1):67-71. doi: 10.1016/s1091-255x(98)80105-4. J Gastrointest Surg. 1998. PMID: 9841970 - Histologic comparison of hereditary nonpolyposis colorectal cancer associated with MSH2 and MLH1 and colorectal cancer from the general population.
Shashidharan M, Smyrk T, Lin KM, Ternent CA, Thorson AG, Blatchford GJ, Christensen MA, Lynch HT. Shashidharan M, et al. Dis Colon Rectum. 1999 Jun;42(6):722-6. doi: 10.1007/BF02236925. Dis Colon Rectum. 1999. PMID: 10378595 - Association of colonic and endometrial carcinomas in Portuguese families with hereditary nonpolyposis colorectal carcinoma significantly increases the probability of detecting a pathogenic mutation in mismatch repair genes, primarily the MSH2 gene.
Lage PA, Albuquerque C, Sousa RG, Cravo ML, Salazar M, Francisco I, Maia L, Claro I, Suspiro A, Rodrigues P, Raposo H, Fidalgo PA, Nobre-Leitão C. Lage PA, et al. Cancer. 2004 Jul 1;101(1):172-7. doi: 10.1002/cncr.20320. Cancer. 2004. PMID: 15222003 - Mutations predisposing to hereditary nonpolyposis colorectal cancer.
Peltomäki P, de la Chapelle A. Peltomäki P, et al. Adv Cancer Res. 1997;71:93-119. doi: 10.1016/s0065-230x(08)60097-4. Adv Cancer Res. 1997. PMID: 9111864 Review. - Hereditary nonpolyposis colorectal cancer (Lynch syndrome): criteria for identification and management.
Kouraklis G, Misiakos EP. Kouraklis G, et al. Dig Dis Sci. 2005 Feb;50(2):336-44. doi: 10.1007/s10620-005-1607-z. Dig Dis Sci. 2005. PMID: 15745097 Review.
Cited by
- Cancer spectrum in DNA mismatch repair gene mutation carriers: results from a hospital based Lynch syndrome registry.
Pande M, Wei C, Chen J, Amos CI, Lynch PM, Lu KH, Lucio LA, Boyd-Rogers SG, Bannon SA, Mork ME, Frazier ML. Pande M, et al. Fam Cancer. 2012 Sep;11(3):441-7. doi: 10.1007/s10689-012-9534-6. Fam Cancer. 2012. PMID: 22714864 Free PMC article. - Inherited colorectal cancer syndromes.
Ellis CN. Ellis CN. Clin Colon Rectal Surg. 2005 Aug;18(3):150-62. doi: 10.1055/s-2005-916276. Clin Colon Rectal Surg. 2005. PMID: 20011298 Free PMC article. - Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC).
Geary J, Sasieni P, Houlston R, Izatt L, Eeles R, Payne SJ, Fisher S, Hodgson SV. Geary J, et al. Fam Cancer. 2008;7(2):163-72. doi: 10.1007/s10689-007-9164-6. Epub 2007 Oct 16. Fam Cancer. 2008. PMID: 17939062 - Survival from colorectal carcinoma in HNPCC families as compared to the general population in Lithuania--initial results.
Elsakov P, Kurtinaitis J. Elsakov P, et al. Fam Cancer. 2006;5(4):369-71. doi: 10.1007/s10689-006-0007-7. Epub 2006 Jul 7. Fam Cancer. 2006. PMID: 16826317 - The predicted impact and cost-effectiveness of systematic testing of people with incident colorectal cancer for Lynch syndrome.
Kang YJ, Killen J, Caruana M, Simms K, Taylor N, Frayling IM, Snowsill T, Huxley N, Coupe VM, Hughes S, Freeman V, Boussioutas A, Trainer AH, Ward RL, Mitchell G, Macrae FA, Canfell K. Kang YJ, et al. Med J Aust. 2020 Feb;212(2):72-81. doi: 10.5694/mja2.50356. Epub 2019 Oct 8. Med J Aust. 2020. PMID: 31595523 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical